VP, Head of Clinical Research and Development
Decibel Therapeutics, Massachusetts
Dr Valayannopoulos, M.D., Ph.D., MBA, is the Vice President and Head of Clinical Development, Medical Affairs and Translational Medicine at Decibel Therapeutics, Boston, MA. With training in pediatric metabolic medicine, clinical genetics and pediatric neurology and prior to joining the pharmaceutical industry, he served as Senior Faculty and Principal Investigator at Necker-Enfants Malades University Hospital, Paris, France. Dr Valayannopoulos conducted clinical research on neurodegenerative genetic diseases, gene therapy and lysosomal storage disorders.
He has served as Principal Investigator and coordinator in several clinical trials and is an author or co-author on numerous peer-reviewed journal articles and textbook chapters.
Dr Valayannopoulos earned his medical degree and completed his pediatric residency program at Paul Sabatier University Medical School in Toulouse, France and has received a Master’s degree in Molecular and Human Genetics, a PhD in Molecular Biology, both from Paris Descartes University and his MBA from MIT Sloan School of Management.
Financial Disclosures: I do not have any relevant financial relationships with anything to disclose.
Non-Financial Disclosures: I do not have any relevant non-financial relationships with anything to disclose.
FS202 - Development of Protective and Restorative Hearing Therapeutics: DB-020 and DB-OTO
Thursday, April 20, 2023
2:30 PM – 4:00 PM PDT